Rapid molecular testing for TB to guide respiratory isolation in the U.S.: A cost-benefit analysis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Millman, Alexander J ^a,b   Dowdy, David W ^c   Miller, Cecily R ^b   Brownell, Robert ^b   Metcalfe, John Z ^a,b   Cattamanchi, Adithya ^a,b   Davis, J Lucian ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST-BENEFIT ANALYSIS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 84894251772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079669     Document Type: Article

References (27)

1. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378: 57-72.
2. Jensen P, Lambert L, Iademarco M, Ridzon R (2005) Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54: 1-141.
3. Pavelchak N, DePersis RP, London M, Stricof R, Oxtoby M, et al (2000) Identification of factors that disrupt negative air pressurization of respiratory isolation rooms. Infect Control Hosp Epidemiol 21: 191-195.
4. Wilmer A, Bryce E, Grant J (2011) The role of the third acid-fast bacillus smear in tuberculosis screening for infection control purposes: A controversial topic revisited. Can J Infect Dis Med Microbiol 22: E1-E3.
5. Moore D, Guzman J, Mikhail L (2005) Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis : 247-252.
6. Tokars JI, McKinley GF, Otten J, Woodley C, Sordillo EM, et al (2001) Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infect Control Hosp Epidemiol 22: 449-455. (Pubitemid 32889278)
7. Wisnivesky J, Henschke C, Balentine J, Willner C, Deloire A, et al (2005) Prospective validation of a prediction model for isolating inpatients with suspected pulmonary tuberculosis. Arch Intern Med 165: 453-457. (Pubitemid 40280203)
8. Catanzaro A, Perry S, Clarridge JE, Dunbar S, Goodnight-White S, et al (2000) The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: Results of a multicenter prospective trial. JAMA 283: 639-645. (Pubitemid 30069180)
9. Greco S, Girardi E, Navarra A, Saltini C (2006) Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 61: 783-790. (Pubitemid 44369403)
10. Campos M, Quartin A, Mendes E, Abreu A, Gurevich S, et al (2008) Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. Am J Respir Crit Care Med 178: 300-305.
11. Laraque F, Griggs A, Slopen M, Munsiff S (2009) Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban setting. Clin Infect Dis 49: 46-54.
12. Drobniewski FA, Watt B, Smith EG, Magee JG, Williams R, et al (1999) A national audit of the laboratory diagnosis of tuberculosis and other mycobacterial diseases within the United Kingdom. J Clin Pathol 52: 334-337. (Pubitemid 29200023)
13. Dowdy DW, Maters A, Parrish N, Breyer C, Dorman S (2003) Cost-effectiveness analysis of the Gen-Probe Amplified Mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Micro 41: 948-953. (Pubitemid 36307091)
14. Hughes R, Wonderling D, Li B, Higgens B (2012) The cost effectiveness of nucleic acid amplification techniques for the diagnosis of tuberculosis. Respir Med 106: 300-307.
15. Dorman S (2009) Editorial commentary: Coming of age of nucleic acid amplification tests for the diagnosis of tuberculosis. Clin Infect Dis 49: 55-57.
16. Dylewski J (2009) Nucleic acid amplification testing for the diagnosis of tuberculosis: Not for all. Clin Infect Dis 49: 1456-1457.
17. Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, et al (2013) The health system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis 5: 532-532.
18. Choi HW, Miele K, Dowdy D, Shah M (2013) Cost-effectiveness of Xpert H MTB/RIF for diagnosing pulmonary tuberculosis in the United States. Int J Tuberc Lung Dis 17: 1328-1335.
19. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, et al (2013) Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593.
20. World Health Organization (2011) Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampin resistance: Xpert MTB/RIF system. A policy statement. Available: http://whqlibdoc.who.int/publications/2011/9789241501545-eng.pdf. Accessed 2013 Oct 30.
21. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
22. FDA permits marketing of first US test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin. FDA News Release July 25th 2013. Available at http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm362602.htm. Accessed on 2013 Aug 26.
23. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America (2000) Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161(4 Pt 1): 1376-95.
24. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, et al (2006) Fluorescence versus conventional sputum smear microscopy for tuberculosis: A systematic review. Lancet Infect Dis 6: 570-581. (Pubitemid 44262344)
25. Dowdy D, O'Brien M, Bishai D (2008) Cost effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1021-1029.
26. Rajalahti I, Ruokonen E, Kotomäki T, Sintonen H, Nieminen MM (2004) Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area. European Respiratory Journal 23: 446-451. (Pubitemid 38344384)
27. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, et al (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353: 444-449. (Pubitemid 29067335)